Company intelligence / Profile preview

Bharat Immunologicals and Biologicals Corporation

Bulandshahr, Uttar Pradesh, India

Ownership: Private
Development stage: Other

Overview

BIBCOL is a public sector company, central to India's polio eradication campaign, with commercialized products including oral polio vaccine, zinc tablets, and iron-folic acid tablets. The company is expanding into oral cholera vaccines and plasma-derived medicines, is selected as a Covaxin manufacturer through technology transfer, and supplies to India's national programs[3][1][5].

Therapeutic areas: HematologyInfectious DiseasesGastroenterology
Modalities: VaccineSmall moleculeBiologic
Industry: Biotech

Partnerships

Department of Biotechnology, Ministry of Science & TechnologyBharat Biotech International (for Covaxin technology transfer)Nutriset (zinc tablet technology)

Beyond the preview

Go deeper on Bharat Immunologicals and Biologicals Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bharat Immunologicals and Biologicals Corporation.

Explore the full profile